Previous issues
-
Previous issues
Volume 28(3) Jul 2022
Print ISSN: 2287-2728
Online ISSN: 2287-285X
- Reviews Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
- Pil Soo Sung
- Clin Mol Hepatol. 2022;28(3):333-350.
- The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection
- Jung Hwan Yu, Soon Gu Cho, Young-Joo Jin, Jin-Woo Lee
- Clin Mol Hepatol. 2022;28(3):351-361.
- Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound
- Junghoan Park, Jeong Min Lee, Tae-Hyung Kim, Jeong Hee Yoon
- Clin Mol Hepatol. 2022;28(3):362-379.
- Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
- Myung Ji Goh, Dong Hyun Sinn
- Clin Mol Hepatol. 2022;28(3):380-395.
- Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance
- Mina Komuta
- Clin Mol Hepatol. 2022;28(3):396-407.
- RNA interference as a novel treatment strategy for chronic hepatitis B infection
- Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2022;28(3):408-424.
- Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
- Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim
- Clin Mol Hepatol. 2022;28(3):425-472.
- Editorials Does nonalcoholic fatty liver disease predispose patients to carotid arteriosclerosis and ischemic stroke?
- Qian Jin, Rui-Xu Yang, Jian-Gao Fan
- Clin Mol Hepatol. 2022;28(3):473-477.
- A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease
- Seonghwan Hwang, Won Kim
- Clin Mol Hepatol. 2022;28(3):478-480.
- Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults
- Byoung Seok Ye
- Clin Mol Hepatol. 2022;28(3):481-482.
- Original Articles Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
- Ansel Shao Pin Tang, Kai En Chan, Jingxuan Quek, Jieling Xiao, Phoebe Tay, Margaret Teng, Keng Siang Lee, Snow Yunni Lin, May Zin Myint, Benjamin Tan, Vijay K Sharma, Darren Jun Hao Tan, Wen Hui Lim, Apichat Kaewdech, Daniel Huang, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J Sanyal, Mark Muthiah, Cheng Han Ng
- Clin Mol Hepatol. 2022;28(3):483-496.
- Discovery of dipeptidyl peptidase-4 inhibitor specific biomarker in non-alcoholic fatty liver disease mouse models using modified basket trial
- Ju Hee Oh, Dae Won Jun, Hye Young Kim, Seung Min Lee, Eileen L. Yoon, Jungwook Hwang, Jung Hwan Park, Hanbi Lee, Wankyu Kim, Hyunsung Kim
- Clin Mol Hepatol. 2022;28(3):497-509.
- Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults
- Seogsong Jeong, Yun Hwan Oh, Seulggie Choi, Jooyoung Chang, Sung Min Kim, Joung Sik Son, Gyeongsil Lee, Joseph C Ahn, Dong Hyeon Lee, Bo Kyung Koo, Won Kim, Sang Min Park
- Clin Mol Hepatol. 2022;28(3):510-521.
- Gut-derived lipopolysaccharide promotes alcoholic hepatosteatosis and subsequent hepatocellular carcinoma by stimulating neutrophil extracellular traps through toll-like receptor 4
- Yang Liu, Xin Zhang, Shuo Chen, Jiazhong Wang, Shuo Yu, Yiming Li, Meng Xu, Harouna Aboubacar, Junhui Li, Tao Shan, Jixin Wang, Gang Cao
- Clin Mol Hepatol. 2022;28(3):522-539.
- Reappraisal of sepsis-3 and CLIF-SOFA as predictors of mortality in patients with cirrhosis and infection presenting to the emergency department: A multicenter study
- Ji Hyun Kim, Baek Gyu Jun, Minjong Lee, Hye Ah Lee, Tae Suk Kim, Jeong Won Heo, Da Hye Moon, Seong Hee Kang, Ki Tae Suk, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim, Dae Hee Choi
- Clin Mol Hepatol. 2022;28(3):540-552.
- Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients
- Ka Shing Cheung, Lok Ka Lam, Rex Wan Hin Hui, Xianhua Mao, Ruiqi R Zhang, Kwok Hung Chan, Ivan FN Hung, Wai Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2022;28(3):553-564.
- The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
- Cheng Han Ng, Kai En Chan, Yip Han Chin, Rebecca Wenling Zeng, Pei Chen Tsai, Wen Hui Lim, Darren Jun Hao Tan, Chin Meng Khoo, Lay Hoon Goh, Zheng Jye Ling, Anand Kulkarni, Lung-Yi Loey Mak, Daniel Q Huang, Mark Chan, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J. Sanyal, Mark Muthiah
- Clin Mol Hepatol. 2022;28(3):565-574.
- Letter to the Editor Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma
- Hideki Iwamoto, Shigeo Shimose, Takashi Niizeki, Hironori Koga, Takuji Torimura
- Clin Mol Hepatol. 2022;28(3):575-579.
- Snapshot Microbiome and metabolomics in alcoholic liver disease
- Raja Ganesan, Ki Tae Suk
- Clin Mol Hepatol. 2022;28(3):580-582.